These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22050337)

  • 1. Potential of bacteriophages and their lysins in the treatment of MRSA: current status and future perspectives.
    Borysowski J; Lobocka M; Międzybrodzki R; Weber-Dabrowska B; Górski A
    BioDrugs; 2011 Dec; 25(6):347-55. PubMed ID: 22050337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolutionarily distinct bacteriophage endolysins featuring conserved peptidoglycan cleavage sites protect mice from MRSA infection.
    Schmelcher M; Shen Y; Nelson DC; Eugster MR; Eichenseher F; Hanke DC; Loessner MJ; Dong S; Pritchard DG; Lee JC; Becker SC; Foster-Frey J; Donovan DM
    J Antimicrob Chemother; 2015 May; 70(5):1453-65. PubMed ID: 25630640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced staphylolytic activity of the Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88 HydH5 virion-associated peptidoglycan hydrolase: fusions, deletions, and synergy with LysH5.
    Rodríguez-Rubio L; Martínez B; Rodríguez A; Donovan DM; García P
    Appl Environ Microbiol; 2012 Apr; 78(7):2241-8. PubMed ID: 22267667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial bioagents based on principles of bacteriophage biology: an overview.
    Knoll BM; Mylonakis E
    Clin Infect Dis; 2014 Feb; 58(4):528-34. PubMed ID: 24270166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lytic activity of the recombinant staphylococcal bacteriophage PhiH5 endolysin active against Staphylococcus aureus in milk.
    Obeso JM; Martínez B; Rodríguez A; García P
    Int J Food Microbiol; 2008 Dec; 128(2):212-8. PubMed ID: 18809219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysis-deficient phages as novel therapeutic agents for controlling bacterial infection.
    Paul VD; Sundarrajan S; Rajagopalan SS; Hariharan S; Kempashanaiah N; Padmanabhan S; Sriram B; Ramachandran J
    BMC Microbiol; 2011 Aug; 11():195. PubMed ID: 21880144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Phage Lysin Fused to a Cell-Penetrating Peptide Kills Intracellular Methicillin-Resistant Staphylococcus aureus in Keratinocytes and Has Potential as a Treatment for Skin Infections in Mice.
    Wang Z; Kong L; Liu Y; Fu Q; Cui Z; Wang J; Ma J; Wang H; Yan Y; Sun J
    Appl Environ Microbiol; 2018 Jun; 84(12):. PubMed ID: 29625989
    [No Abstract]   [Full Text] [Related]  

  • 8. LYSIS-FROM-WITHOUT OF STAPHYLOCOCCUS AUREUS STRAINS BY COMBINATIONS OF SPECIFIC PHAGES AND PHAGE-INDUCED LYTIC ENZYMES.
    RALSTON DJ; MCIVOR M
    J Bacteriol; 1964 Sep; 88(3):676-81. PubMed ID: 14208506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Typing of Panton-Valentine leukocidin-encoding phages carried by methicillin-susceptible and methicillin-resistant Staphylococcus aureus from Italy.
    Sanchini A; Del Grosso M; Villa L; Ammendolia MG; Superti F; Monaco M; Pantosti A
    Clin Microbiol Infect; 2014 Nov; 20(11):O840-6. PubMed ID: 24835735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The phage K lytic enzyme LysK and lysostaphin act synergistically to kill MRSA.
    Becker SC; Foster-Frey J; Donovan DM
    FEMS Microbiol Lett; 2008 Oct; 287(2):185-91. PubMed ID: 18721148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CELL-WALL LYSINS OF STAPHYLOCOCCUS AUREUS STRAINS INDUCED BY SPECIFIC TYPING PHAGES.
    RALSTON DJ; MCIVOR M
    J Bacteriol; 1964 Sep; 88(3):667-75. PubMed ID: 14208505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are Phage Lytic Proteins the Secret Weapon To Kill
    Gutiérrez D; Fernández L; Rodríguez A; García P
    mBio; 2018 Jan; 9(1):. PubMed ID: 29362234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary treatment of bovine mastitis caused by Staphylococcus aureus, with trx-SA1, recombinant endolysin of S. aureus bacteriophage IME-SA1.
    Fan J; Zeng Z; Mai K; Yang Y; Feng J; Bai Y; Sun B; Xie Q; Tong Y; Ma J
    Vet Microbiol; 2016 Aug; 191():65-71. PubMed ID: 27374909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A genetic screen to identify bacteriophage lysins.
    Schuch R; Fischetti VA; Nelson DC
    Methods Mol Biol; 2009; 502():307-19. PubMed ID: 19082564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Phage Lysins as Novel Therapeutics: A Historical Perspective.
    Fischetti VA
    Viruses; 2018 Jun; 10(6):. PubMed ID: 29875339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel
    Cater K; Dandu VS; Bari SM; Lackey K; Everett GF; Hatoum-Aslan A
    mSphere; 2017; 2(2):. PubMed ID: 28357414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriophage lytic enzymes: novel anti-infectives.
    Fischetti VA
    Trends Microbiol; 2005 Oct; 13(10):491-6. PubMed ID: 16125935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A potent enzybiotic against methicillin-resistant Staphylococcus aureus.
    Kaur J; Singh P; Sharma D; Harjai K; Chhibber S
    Virus Genes; 2020 Aug; 56(4):480-497. PubMed ID: 32367411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lytic activity of recombinant bacteriophage phi11 and phi12 endolysins on whole cells and biofilms of Staphylococcus aureus.
    Sass P; Bierbaum G
    Appl Environ Microbiol; 2007 Jan; 73(1):347-52. PubMed ID: 17085695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of a Novel Lytic Bacteriophage against a Nosocomial Methicillin-Resistant
    Pertics BZ; Szénásy D; Dunai D; Born Y; Fieseler L; Kovács T; Schneider G
    Biomed Res Int; 2020; 2020():5463801. PubMed ID: 33426055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.